Can Glimepiride Be Taken Twice Daily?
No, glimepiride should be taken once daily with breakfast or the first main meal, as this is the FDA-approved dosing regimen that provides effective 24-hour glycemic control. 1
FDA-Approved Dosing
The FDA label explicitly states that glimepiride should be administered once daily with breakfast or the first main meal 1. The recommended starting dose is 1-2 mg once daily, with uptitration in 1-2 mg increments every 1-2 weeks based on glycemic response, up to a maximum of 8 mg once daily 1. This once-daily dosing is the standard of care and reflects the drug's pharmacokinetic profile.
Evidence Supporting Once-Daily Dosing
Research directly comparing once-daily versus twice-daily administration demonstrates that both regimens are equally effective, but once-daily dosing is clinically preferred 2, 3. Key findings include:
- A 15-week crossover study of 161 patients showed that 6 mg once daily was equally effective as 3 mg twice daily in reducing fasting, postprandial, and 24-hour mean glucose concentrations 2
- An 8-patient Japanese crossover study confirmed similar pharmacodynamic profiles (glucose, insulin, C-peptide) between once-daily and twice-daily regimens, despite different pharmacokinetic profiles 3
- Patient compliance is significantly superior with once-daily dosing: 87% mean daily compliance versus 80% with twice-daily dosing (p<0.0001), and 87% days with adequate compliance versus 67% (p<0.0001) 4
- Treatment satisfaction scores were significantly higher with once-daily administration 4
Clinical Rationale
Glimepiride's mechanism appears to stimulate insulin production primarily during postprandial glucose peaks while maintaining control throughout the day 2. The drug's pharmacokinetics support once-daily dosing, with peak concentrations occurring 2 hours after administration regardless of dose 3. The once-daily regimen simplifies the treatment regimen without compromising efficacy.
Important Caveats
- Elderly patients and those with renal impairment should start at 1 mg once daily due to increased hypoglycemia risk 1
- In chronic kidney disease, initiate glimepiride conservatively to avoid hypoglycemia 5
- Glyburide (a different sulfonylurea) is generally not recommended in CKD, but glimepiride and glipizide can be used with caution 5
Bottom Line
Prescribe glimepiride as once-daily dosing with breakfast. While twice-daily administration is pharmacologically feasible and equally effective for glycemic control, it offers no clinical advantage and significantly reduces patient compliance. The FDA-approved once-daily regimen should be followed in clinical practice.